Kuehr, T; Burgstaller, S; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Greil, R; Michlmayr, G; Lutz, W; Thaler, J.
Interferon alpha in combination with intermittent versus continuous YNK01 in patients with CML in early chronic phase: Preliminary results of a randomized phase III study.
BLOOD 2002 100: 328B-328B.
Web of Science